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A B S T R A C T
Coronary artery stent infection has been reported with both bare metal stent and drug eluting stent and
can present as mycotic coronary artery aneurysm, pseudoaneurysm, myocardial abscess, pericarditis or
exudative effusion. Infection at the site of coronary stent implantation is rare and is believed to result
typically from either direct stent contamination at the time of delivery or transient bacteraemia from
access site. Introduction of drug-eluting stent (DES) has led to a marked reduction in the problem of in-
stent restenosis across all patient subsets and lesions complexities. Recently, several case reports of
pseudoaneurysm formation after DES implantation have been reported in the literature.We describe the
successful surgical management of giant mycotic pseudoaneurysm of left anterior descending artery
(LAD) presenting as fever of unknown origin. This report illustrates the importance of early detection and
prompt management of these rare coronary pseudoaneurysms, which is a highly lethal condition.
 2016 Cardiological Society of India. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Case report
A 51-year-old male presented with a history of a primary
placement of drug eluting stent to LAD about a year back for a
discrete block in mid LAD for acute myocardial infarction at some
other hospital. Left ventricular ejection fraction (LVEF) at that time
was normal. Patient was otherwise non-diabetic and non-
hypertensive. One month after primary stenting to LAD and
during routine follow-up, patient was detected to have developed
pseudoaneurysm of LAD in 2D echocardiography. Diagnosis was
reconﬁrmed on angiography and was managed by concerned
cardiologist by putting a covered stent (nature of stent was not
known in both cases). About 6 months after the redo PTCA, patient
was admitted to the same hospital with complaints of generalized
weakness and fever. Patient was discharged after a course of
antibiotics. The LVEF on transthoracic echo had declined to 40%.
Six months later, patient was admitted at our hospital with
high-grade fever and chest pain. An urgent echo revealed a large
pseudoaneurysm of LAD projecting anterior to left ventricle and
extending till pulmonary artery. The aneurysm was partially
thrombosed. There was to and fro ﬂow of blood through a narrow* Corresponding author at: Hno 3995, Janglian Street, Fazilka 152123, Punjab,
India.
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http://dx.doi.org/10.1016/j.ihj.2016.08.006
0019-4832/ 2016 Cardiological Society of India. Published by Elsevier B.V. This is an
licenses/by-nc-nd/4.0/).neck. There was also global hypokinesia with LVEF of 20%. Only the
inferior and lateral walls of LV were moving. There was mild to
moderate mitral regurgitation (MR) also.
Blood cultures were sent and empirical antibiotics were started
as per hospital infection protocol.
Coronary computed tomography angiography revealed a large
9 cm 6 cm aneurysm of LAD (Fig. 1) with peripheral thrombus.
The stent in arterywas blockedwithnodistal ﬂow seen in the artery.
Left circumﬂex (LCX) was small. The stent was visible ﬂoating in the
cavity of the pseudoaneurysm. Thewhole of left side of the heart had
no large vessel on angiography. The right coronary artery was
dominant, huge and supplying the inferior and lateral wall (Fig. 2).
Admission laboratory studies were notable for thrombocyto-
penia and an elevated Troponin I level. The electrocardiography
showed poor progression of R wave in leads V1–V6.
The preliminary blood cultures reports were sterile. However,
the fever was persisting in spite of 2 days of injectable Meropenam
and Teicoplanin which were started empirically. By day 5 of
admission, the patient had become afebrile. Final blood culture
report after 5 days of incubation was also sterile. It was decided to
operate on the patient.
On hospital day 6, patient was taken up for surgery. The
intraoperative transesophageal echocardiography (TEE) conﬁrmed
the presence of a 7.5 cm pseudoaneurysm on the anterior surface
of the heart with mild mitral regurgitation and a low LVEF of 20%
(Fig. 3).open access article under the CC BY-NC-ND license (http://creativecommons.org/
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Fig. 2. Conventional catheter angiography showing dye from LAD entering into
aneurysm. Two stents are also visible.
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Fig. 3. Intraoperative TEE showing large aneurysm abutting LV wall.
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Fig. 4. Intraoperative view of opened coronary aneurysm.
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Fig. 1. CT angiography showing large aneurismal cavity with narrow neck.
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Fig. 5. The covered stent recovered from aneurysm cavity.
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coronary pseudoaneurysmectomy. Intraoperative ﬁndings includ-
ed extensive 8 cm pseudoaneurysm of the LAD (Fig. 4). The
pseudoaneurysm was cleaned of the thrombus in which the stent
was also found (Fig. 5). The primary stent could not be located. The
thrombus and necrotic material was sent for culture and
sensitivity. The narrow neck of the pseudoaneurysm was formed
by proximal LAD. LAD opening in pseudoaneurysm was closed by
pledgeted sutures. All necrotic tissue was excised, a reverse-
saphenous vein graft (rSVG) to the ﬁrst obtuse marginal branch
and rSVG to LAD were grafted. The resected aneurysm wall was
sent to pathology for further analysis. An intraaortic balloon pump
(IABP) was placed before coming off cardiopulmonary bypass. TEE
showed only mild MR not requiring any intervention. The
operation was otherwise uneventful.
On postoperative day (POD) 1, the patient was extubated. By
POD 3, EF had increased to 30% and the IABP was taken out.
The culture report of the pseudoaneurysm material showed
pseudomonas infection which was sensitive to most antibiotics,
including the ones he was already on.Post-IABP removal, he had few episodes of non-sustained
ventricular tachycardia.
So, an implantable cardioverter deﬁbrillator was implanted and
patient was discharged home on POD 15 on oral antibiotics for
8 weeks.
2. Discussion
The development of a mycotic coronary pseudoaneurysm is a
rare entity being ﬁrst reported by Bougon in 1812.1,2 The majority
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rosis with congenital aneurysms, vasculitis (e.g., Kawasaki
syndrome) and connective tissue disorders.1–3 A distinct occur-
rence is a mycotic coronary pseudoaneurysm (MCA) post-
percutaneous coronary intervention (0.3–0.6%) with only 19 cases
reported in the international literature.4 Mechanical factors,
infection and inﬂammation are three major contributors reported
to lead to the development of mycotic coronary pseudoaneurysms
in these cases.4 The arterial wall injury caused by oversized
balloons and stents might be the potential mechanical factors,
Staphylococcus aureus is the primary infectious agent in the
majority of cases. The direct stent contamination at the time of
delivery, repeated femoral access and femoral artery sheaths left in
place for a long duration may facilitate bacteraemia of S. aureus,
which is a normal skin commensal.4 Late stent infection may be
caused by drug-eluting stent related local problems like delayed
endothelialization of the stent struts, inhibition of neointimal
growth, late incomplete healing of any injury, stent apposition, and
coronary aneurysm formation.5,6 Coronary pseudoaneurysms have
been reported from 3 days to up to 4 years after DES implantation
procedures, with varying clinical presentations.7,8
Interestingly, our patient had pseudomonas infectionwhich has
also been reported by Chen et al.4 in 3 of 19 patients as etiological
organism.
Potential complications secondary to mycotic coronary pseu-
doaneurysms include rupture, cardiac tamponade, ﬁstulisation,
myocardial ischemia or infarction secondary to septic emboliza-
tion and sudden cardiac death.5,6
In this case the huge mycotic pseudoaneurysm had formed
slowly over a year after a breach in the LAD arterial wall following
the percutaneous transluminal coronary angioplasty (PTCA) and
subsequent pseudomonas bacteraemia from the infected stent.
Coronary ligation with resection appears to offer the most
uncomplicated approach, assuming viable target vessels exist for
grafting. Given the proximity of the LAD ostium and distal portion
of the left main artery to the infected aneurysm, the proximal LAD
was bypassed with an rSVG and another saphenous vein was
grafted to obtuse marginal branch that was compressed by thepseudoaneurysm. In view of low LVEF, dense adhesions of
pericardium to chest wall and active infection in the area, internal
mammary artery was not harvested. Without appropriate target
vessels, the complexity of such a surgical approach increases
signiﬁcantly.
The unusual nature was because of the huge size, compression
of the circumﬂex artery by aneurysm and infection of the
aneurysm by pseudomonas in an otherwise healthy 51-year-old
male. Given the limited experience with huge LAD pseudoaneur-
ysm, clinical management is still evolving, as the majority of
reported cases have been documented post-mortem.1
As evidenced by this case, correlating ﬁndings between the CT
angiogram, coronary angiogram and TEE is of paramount impor-
tance in the management of these rare coronary pseudoaneur-
ysms. Early diagnosis, appropriate antibiotic therapy and prompt
surgery remain the mainstay of current therapy.
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